We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · June 02, 2015

Bioresorbable Vascular Scaffolds in Coronary Syndromes: 12-Month Outcomes

JACC: Cardiovascular Interventions

 

Additional Info

Disclosure statements are available on the authors' profiles:

JACC: Cardiovascular Interventions
Clinical, Angiographic, Functional, and Imaging Outcomes 12 Months After Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary Syndromes
JACC Cardiovasc Interv 2015 May 01;8(6)770-777, T Gori, E Schulz, U Hink, M Kress, N Weiers, M Weissner, A Jabs, P Wenzel, D Capodanno, T Münzel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading